W Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, Nicolas Anselmino, Nathalie Bock, Nicholas Choo, Ashlee K Clark, Ilsa M Coleman, Robin Dolgos, Alison M Ferguson, David L Goode, Marianna Krutihof-de Julio, Nora M Navone, Peter S Nelson, Edward O'Neill, Laura H Porter, Weranja Ranasinghe, Takuro Sunada, Elizabeth D Williams, Lisa M Butler, Eva Corey, Wytske M van Weerden, Renea A Taylor, Gail P Risbridger, Mitchell G Lawrence
BACKGROUND: There are relatively few widely used models of prostate cancer compared to other common malignancies. This impedes translational prostate cancer research because the range of models does not reflect the diversity of disease seen in clinical practice. In response to this challenge, research laboratories around the world have been developing new patient-derived models of prostate cancer, including xenografts, organoids, and tumor explants. METHODS: In May 2023, we held a workshop at the Monash University Prato Campus for researchers with expertise in establishing and using a variety of patient-derived models of prostate cancer...
March 7, 2024: Prostate